National Beverage Corp. (FIZZ): what the price assumes

In the published model solve dated 2026-Q2, anchored at $32.24, National Beverage Corp. (FIZZ) is priced for -4.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-26.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/FIZZ

Headline

FieldValue
TickerFIZZ
CompanyNational Beverage Corp.
Sector / IndustryConsumer Defensive
Current price$32.24/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)6.7%
Operating margin today19.5%
Margin compression (value-band)-12.8pp
Implied growth-4.8%
Multiple paid12x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.2% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.47σ
cohort percentile (of 69 peers)12

Valuation X-Ray

The price is justified by relative-multiple; asset-based/earnings-power/growth-DCF land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.52x5expensive
Earnings1.56x4expensive
Relative0.80x3justifies
Growth1.58x3expensive

Families that justify the price: Relative Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$20.451.58xyesFCF base $0.2B, growth -2% (input: historical growth), terminal g 0.5%, WACC 9.0%, 5yr projection
DCF Exit MultipleGrowth$29.941.08xyesExit EV/EBITDA: 9.1x / 11.1x / 13.1x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$41.580.78xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.7x / 22.0x / 25.3x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$21.211.52xyesBV/sh $6.79, ROE (TTM) 28.9%, ke 9.3%
Two-Stage Excess ReturnAsset$38.430.84xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$19.421.66xyesRev $1.2B, growth -2% (input: historical growth; tapered), Terminal P/S: 2.2x / 2.6x / 2.9x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$21.701.49xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.22B × (1−24%) / WACC 9.0% → EPV (no growth)
Residual IncomeAsset$32.151.00xyesBV $6.79 + 5yr PV of (ROE (TTM) 28.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$17.311.86xyes√(22.5 × EPS $1.96 × BVPS $6.79) — Graham's conservative floor
EV/EBITDA RelativeRelative$40.050.80xyesEBITDA $0.25B × sector EV/EBITDA 14.0x
FCF YieldEarnings$20.271.59xyesFCF $156.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$8.064.00xyesEPS $1.96 × (8.5 + 2×-1.8%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$6.764.77xyesBV $6.79 × (ROIC 9.0% / WACC 9.0%)
P/Sales SectorRelative$25.221.28xyesRevenue $1.18B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$21.191.52xyesEPS $1.96 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$349.5m
Net debt / NOPAT (after-tax)-1.99x (net cash)
Net debt / operating income (pre-tax)-1.52x (net cash)
Share count CAGR (dilution)0.0%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Maturity is not an insult in the beverage business. It means the growth argument has already been settled and the interesting question becomes what share of each dollar the company keeps, and who has a claim on the rest. National Beverage answers the first half of that cleanly. Fiscal 2026 net sales of $1,180.6 million produced operating income of $230.1 million, within a few million dollars of the $235.5 million booked the year before on one extra selling week. For a company selling flavored water and regional soda into the most contested shelf space in American retail, that steadiness is most of the case.

The mechanic behind it is unusual and worth a minute. Most beverage companies own trucks, drivers and route density. This one largely does not. Product leaves the plants on the retailer's own logistics, and the 10-K puts the benefit on the customer's side of the ledger: "This method allows our retail partners to further maximize their assets by utilizing their ability to pick up product at our warehouses". The marketing budget follows the same instinct. The company states plainly that "innovative marketing, packaging and consumer engagement is more effective in today's marketplace than traditional higher-cost national advertising". LaCroix was built on can design and word of mouth rather than national television inventory, and the saving shows up where you would expect it to: selling, general and administrative expense of $207.2 million in fiscal 2026, or 17.5% of net sales.

Pricing is where durability shows. The 10-K reports that "Average selling price per case increased by 5.2%" during fiscal 2026, while the average cost of sales per case rose 5.0%. Input inflation went through to the shelf and a sliver stayed behind. Gross profit came to $437.3 million against $443.9 million the prior year, a decline of roughly one and a half percent in a year that carried one fewer selling week than the one before it. That is a brand doing the job brands exist to do.

The funding picture changes how the rest reads. Interest paid across the whole of fiscal 2026 came to $278 thousand, a rounding item, while interest income ran $10.6 million against $9.3 million the year before, because the money sits on the company's side of the ledger and earns a return there. Working capital rose $191.4 million to $457.8 million. Capital spending was $25.1 million, down from $36.3 million, against a plant base the company describes as having adequate capacity. A business with that shape does not need anyone's permission to keep operating through a soft patch.

Set against its own cohort, the profitability holds up better than the size would suggest. KDP converts 20.8% of revenue into operating profit and MNST 29.3%, while COKE manages 13.3%, COCO 14.7%, and CELH, the fastest grower in the group, only 7.7% as it buys shelf position. National Beverage keeps close to twenty cents on the dollar, which puts it in the upper half of that set without owning a distribution fleet or paying for the advertising that usually comes with a national brand. Being small has not cost this company margin.

Bear Case

What the market is asking of this business is modest, and that is precisely what makes it fragile. It does not require growth. It requires the profit line to hold roughly where it is, or to fade gently. Fiscal 2026 shows how the holding was done: cases sold fell 6.7%, and the earnings were defended by charging more for each of the cases that still moved. Run that trade another year or two and the question stops being about input costs and becomes whether the shopper is walking.

The 10-K attributes the volume decline to outside forces, listing "government shutdowns, funding changes, inflation and cautious consumer spending". Some of that is real and none of it is controllable. But the same filing notes the decline hit the Power+ Brands, where LaCroix lives, and the carbonated soft drink brands at the same time. When a health-forward growth portfolio and a set of century-old regional sodas soften together, category mix is not the tidiest explanation available. The shelf tag is.

The competitive set is not standing still either. The filing concedes that rivals "have greater financial resources" and lists the ground the fight happens on: "price and promotional activity, advertising and marketing programs, point-of-sale merchandising, retail space management, customer service, product differentiation, packaging innovations and distribution methods". Most of those are line items a bigger balance sheet can simply outspend. Over the trailing year CELH grew revenue 123% and MNST 18%, while National Beverage's went the other way. Retail shelf space is finite and it gets allocated to whatever is turning.

Then there is the fee. The company is managed under an agreement with "Corporate Management Advisors, Inc. (CMA), a corporation owned by its Chairman and Chief Executive Officer", and the arrangement provides for "an annual base fee equal to one percent of the consolidated net sales of the Company". That came to $11.8 million in fiscal 2026 and $12.0 million the year before. Note what the fee is indexed to. Sales, not profit. So in a year when volume fell and management defended earnings by lifting the shelf tag, the fee tracked the top line, and it did so without anyone having to negotiate for it. Shareholder buybacks over the same period were a rounding error: 20,000 shares retired across fiscal 2026 for a total outlay of 0.7 million dollars, against an authorization with roughly 1.9 million shares still open.

And the apparent cheapness rests on a single lens. Peer multiples are the one family of method that reaches today's price; the asset-value, earnings-power and cash-flow approaches all land underneath it, by margins that are not small. A sector multiple applied to a company whose sales are shrinking while the sector's are growing is a comparison that flatters. Should operating profit slip from the $230.1 million it earned in fiscal 2026, the multiple that looks undemanding gets applied to a smaller number, and the holder discovers that cheap had been doing the work of a thesis.

Valuation

Strip out the money the company holds and the operating business is valued at about 11 times operating income. Run that backwards, at an 8.2% cost of capital with 4% terminal growth over a five-year stage, and the arithmetic hits a floor: what the market pays sits below what even a 5% annual decline in operating profit would warrant. That is a bound rather than a solved point, and it is worth stating plainly what it means. The market is not asking this company to grow. It is not asking it to hold flat either.

The methods used to triangulate a business like this do not agree, and the shape of the disagreement is the useful part. Peer multiples are the one lens that reaches the price and reaches comfortably past it: measured on what the beverage sector fetches per dollar of sales and of earnings, the shares look unremarkable. The other three land underneath. The price sits about 45% above where the asset-value lens comes out, about 48% above the earnings-power lens, and about 50% above the cash-flow lens.

The reason for that split is not mysterious. The methods landing below all capitalize what the company earns today and credit nothing beyond it. One takes normalized operating profit averaged over five years, taxes it, and divides by the cost of capital. Another does the same with what the business throws off after capital spending, at a 9.3% required return. Neither carries a dollar of future growth, and against revenue that has drifted sideways for three years that is a defensible starting point rather than a gloomy one. The peer lens asks a different question entirely: what do other beverage companies fetch, and what would this one fetch on the same terms. Both readings are honest. The shares trade between them.

Against the cohort the multiple genuinely is low, in the lower half of the peer range. Growth is why. COCO grew revenue 23% over the trailing year and COKE 8.8%, while National Beverage's revenue fell, and the market pays for the direction of travel as much as for the level of profitability. What it is not paying for here is leverage risk, because there is none to speak of: "At May 2, 2026, we had no outstanding borrowings" is the whole of the fiscal-year-end funding discussion, and interest paid across the year came to $278 thousand.

The share count has not moved in four years, so there is no dilution for a buyer to absorb and no quiet retirement happening either. What the company does with the money instead is accumulate it and then release it in lumps. $304.1 million went out as a special dividend in July 2024, and the board declared another $3.25 a share on July 1, 2026, payable by the end of that month. The timing of the return is therefore the board's decision rather than the calendar's.

Catalysts

The dominant near-term event has already been declared. On July 1, 2026 the board announced a special dividend of $3.25 a share, to holders of record on July 13 and payable on or before July 30. The shares went ex on July 13, 2026. It is the second such payment in three years: the July 2024 distribution was $304.1 million, at the identical rate per share. The practical effect is that the balance-sheet build of fiscal 2026 leaves the company this month rather than sitting there.

The same date carried the fiscal 2026 results. Net sales came in at $1,180.6 million against $1,201.4 million the prior year, on a 52-week year versus 53 weeks, and net income was $183.6 million against $186.8 million. Case volume fell 6.7% and the average selling price per case rose 5.2%, which is the whole story of the year in two numbers. Capital spending was cut to $25.1 million from $36.3 million, so management is not currently building capacity into the volume decline.

The next scheduled information event is the first quarter of fiscal 2027, due September 10, 2026. Two things in that print matter more than the earnings figure. The first is whether the volume decline moderates now that the comparison base is lower. The second is whether the average selling price per case is still climbing, because that has been the entire defense of the profit line, and the quarter after a large distribution is also the first look at how quickly the company rebuilds its position.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2026 10-K subsequent events, filed July 1, 2026 · stockanalysis.com dividend calendar, July 2026 · FY2026 10-K, filed July 1, 2026 · stockanalysis.com earnings calendar, July 2026

View the full interactive FIZZ report on boothcheck